News We’re Watching: AHA Meeting In Philly; Surgeons Call For TAVR Caution; China Approves J&J's Monarch Robot

New clinical trial data presented at the American Heart Association Scientific Sessions in Philadelphia dominated the R&D news this week. Here are some of the highlights from the conference as well as some other bits of medtech industry news you may have missed.

Industry News We're Watching
• Source: Shutterstock

The Society of Thoracic Surgeons (STS) and European Association for Cardio-Thoracic Surgery (EACTS) are recommending “caution” to patients, surgeons and interventionalists before adopting transcatheter aortic valve replacement (TAVR) as the first option for low-risk patients who need a new aortic valve.

New results from two major clinical trials suggested TAVR is a safe and effective alternative to surgery in patients at...

More from Approvals

More from Policy & Regulation